NRP1 and infection: Saiz et al., in their in-vitro study, have shown that HDAC inhibitor Valproic acid (VPA) reduces ACE2 expression significantly [121] and Neuropilin-1 (NRP1) on the cell surface, and the effect remains post-infection of SARS-CoV-2 [122].